Printer Friendly

HemoSense Signs Agreement with Reliant to Distribute INRatio for Home INR Testing.

SAN JOSE, Calif. -- HemoSense, Inc. (AMEX:HEM) today announced that it has signed a distribution agreement with Reliant Healthcare Solutions, Inc. to market and distribute HemoSense's INRatio(R) Prothrombin Time (PT)/INR Monitoring system to patients on oral anticoagulant therapy who wish to test their PT/INR at home.

Reliant will exclusively offer INRatio to its customers, and intends to provide personalized reimbursement assistance to patients, including insurance claims filing and documentation processing. New INRatio customers will also be eligible for face-to-face training from Reliant's nationwide network of healthcare professionals.

"INRatio allows patients to self-test their PT/INR easily and frequently at home. We hope many warfarin patients take advantage of Reliant's personalized services and training to help them get started with INRatio, and we are glad to add Reliant to our patient self-testing distribution network," said Timothy Still, executive vice president of sales and marketing for HemoSense.

Shari Kipp, Reliant's director of sales and marketing, added, "INRatio's simple test procedure makes it a perfect match for our network of face-to-face trainers, and we are excited to partner with HemoSense to offer patients the time savings and health benefits of home INR testing with INRatio."

About HemoSense

HemoSense develops, manufactures and markets easy-to-use, handheld blood coagulation systems for monitoring patients taking warfarin. The HemoSense INRatio system, used by healthcare professionals and patients themselves, consists of a small monitor and disposable test strips. It provides accurate and convenient measurement of blood clotting time, or PT/INR values. Routine measurements of PT/INR are necessary for the safe and effective management of the patient's warfarin dosing. INRatio is sold in the United States and internationally. For more information, visit

About Reliant

Reliant Healthcare Solutions is a U.S. provider of home PT/INR testing supplies and related services for eligible Medicare and privately insured individuals, and offers INRatio exclusively to its customers. For more information, call 1-877-INR-AIDE (1-877-467-2433) toll free or send a request to Reliant Healthcare Solutions, 123 E. San Carlos Street #401, San Jose, Calif. 95112.

HemoSense(R) and INRatio(R) are registered trademarks of HemoSense, Inc.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Feb 28, 2006
Previous Article:Eaton Vance Insured Municipal Bond Funds Declare Monthly Distributions.
Next Article:Cadence Elects CA's John Swainson to Its Board of Directors.

Related Articles
Geriatric Pharmacy Educational Series. (Product Spotlight).
Selected abstracts. (*) (Special Feature).
FP4 Utility of and patient satisfaction with a point-of-care anticoagulation monitoring system in a family practice residency program. (Family...
Preliminary experience with the use of recombinant factor VIIa to treat coagulation disturbances in pediatric patients. (Original Article).
Medication-monitoring lawsuit: case study and lessons learned; another real-life case in nursing home litigation. (Feature Article).
Clinical correlation between effective anticoagulants and risk of stroke: are we using evidence-based strategies?
Analyze this: inside the one spy agency that got pre-war intelligence on Iraq--and much else--right.
Preventing warfarin-related bleeding.
HemoSense Signs Agreement with ZyCare to Distribute INRatio and Utilize Web-Based Warfarin Patient Management System.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters